Interpace Biosciences, Inc. (IDXGD)

OTCMKTS · Delayed Price · Currency is USD

6.91

+0.40 (6.18%)

At close: Sep 4, 2026

Interpace Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	36.14	38.73	46.93	40.04	31.84	33.12
Revenue Growth	-20.48%	-17.47%	17.21%	25.75%	-3.86%	2.22%
Gross Profit	23.04	24.13	29.93	25.06	18.23	18.8
Operating Income	4.18	4.78	8.11	3.96	-3.84	-5.76
Net Income	24.45	24.58	6.24	1.95	-21.96	-14.94
Earnings Per Share	4.46	4.43	6.97	2.24	-25.91	-18.07
EPS Growth	24.12%	-36.52%	210.60%	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2.69	2.51	1.46	3.5	4.83	2.67
Total Debt	0.97	1.18	5.86	11.19	16.09	10.72
Net Cash (Debt)	1.71	1.32	-4.4	-7.69	-11.26	-8.05
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.31	0.24	-1.40	-8.82	-13.29	-9.74

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.46	5.83	4.65	3.79	-7.69	-8.72
Capital Expenditures	-0.35	-0.36	-0.88	-0.47	-0.32	-0.35
Free Cash Flow	4.1	5.48	3.77	3.32	-8.01	-9.07
Free Cash Flow Growth	-2.35%	45.23%	13.59%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	63.75%	62.31%	63.77%	62.58%	57.26%	56.78%
Operating Margin	11.55%	12.35%	17.28%	9.90%	-12.06%	-17.41%
Pretax Margin	11.06%	9.74%	14.81%	5.70%	-18.33%	-23.38%
Profit Margin	67.64%	63.45%	13.29%	4.88%	-68.97%	-45.12%
FCF Margin	11.36%	14.14%	8.03%	8.29%	-25.17%	-27.40%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	1.52	0.22	1.90	2.40	-	-
Forward PE	-	111.43	111.43	111.43	111.43	111.43
P/FCF Ratio	9.33	1.00	3.15	1.41	-	-
PS Ratio	1.06	0.14	0.25	0.12	0.14	0.94